We aimed to evaluate the correlation between the histological grade of endo
metrial cancer diagnosed on endometrial biopsy or curettage, with the defin
itive grade and stage of lesion as determined by surgery and histopathologi
cal examination and to make recommendations about the suitability of conser
vative surgery based on pre-operative determination of the grade of endomet
rial adenocarcinoma.
A retrospective review of all patients with endometrial adenocarcinoma pres
enting to the Queensland Centre for Gynaecological Cancer from 1 January 19
96 to 31 December 1998 was undertaken. Clinical and pathological data was a
bstracted from medical records and case notes of 460 patients. All histolog
ical specimens were prospectively reviewed by a panel consisting of gynaeco
logic pathologists, gynaecologic oncologists and other doctors involved in
the treatment of patients with gynaecological malignancies. The percentage
of patients whose management would have been optimised by full surgical sta
ging at the time of initial surgery was calculated. Only 60%, 71%, and 84%
of the patients with a presenting diagnosis of grade 1, 2 and 3 endometrial
adenocarcinomas respectively had this confirmed on final histopathology. F
urthermore, using established criteria, 30%, 46% and 100% of patients prese
nting with grade 1, 2 and 3 endometrial adenocarcinoma required full surgic
al staging at the time of their primary surgery.
There is poor correlation between the pre-operative grade of endometrial ca
ncer and the grade as determined on analysis of the resected uterus. The co
rrelation is poorest with grade 1 endometrial adenocarcinoma, where stronge
st consideration is given to conservative surgery and the avoidance of subs
pecialty referral. There is a strong argument that all patients with a diag
nosis of endometrial cancer made on endometrial biopsy or curettage, regard
less of grade of malignancy, should be offered surgery where the option to
perform concurrent comprehensive surgical staging is available.